Correction to: ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma (Journal of Experimental & Clinical Cancer Research, (2021), 40, 1, (23), 10.1186/s13046-020-01821-6)

Abstract

Following publication of the original article [1], the authors identified minor errors in image-typesetting in Fig. 1; specifically in panels presented in Fig 1c, d, f and g. The corrected figure and caption are given below. In addition, sections of the mainbody text have been corrected in light of the above. In the ‘Results’ section, under the heading ‘Highly expressed ACTN1 predicts a poor clinical outcome in HCC patients’, the following sentences have been corrected (emphasis given to affected areas):.